ADVFN US – Market Content Editor

New long-term crude oil marketing agreements increase Vivakor’s recurring commercial platform to approximately 18.4 million barrels annually, expanding its integrated energy business. Key Investor Takeaways Why VIVK Stock Is in Focus Vivakor (NASDAQ:VIVK) announced the execution of two additional long-term recurring physical crude oil marketing programs that are expected to add approximately $400 million in…

The company is broadening its GUTSI™ product portfolio by extending its fulvic and humic mineral platform across beverages, supplements, and functional nutrition products. Key Investor Takeaways Why VMHG Stock Is in Focus Victory Marine Holdings (OTCQB:VMHG), through its subsidiary Dunn & Groux Beverage Holdings, announced the continued expansion of its GUTSI™ mineral-first wellness platform, bringing…

The company has started experimental testing of its Texatron™ Fusion Engine, completing initial laboratory preparations and remote ignition system verification before broader engineering evaluations. Key Investor Takeaways Why AMFN Stock Is in Focus American Fusion (OTCQB:AMFN) announced the launch of its planned Texatron™ testing program at Texas Tech University following the successful completion of initial…

Strong international demand growth and lower operating expenses supported improved profitability metrics as Amarin reaffirmed confidence in its global commercialization strategy. Key Investor Takeaways Why AMRN Stock Is in Focus Amarin (NASDAQ:AMRN) reported second-quarter 2026 total net revenue of $42.2 million, down 42% from the prior year. The decline primarily reflected the absence of the…

The merger will create a publicly traded company focused on advancing Caldera’s lead inflammatory bowel disease therapy, with financing expected to fund operations into 2029. Key Investor Takeaways Why SYBX Stock Is in Focus Synlogic (OTCQB:SYBX) announced a definitive merger agreement with clinical-stage biotechnology company Caldera Therapeutics in an all-stock transaction that will transform Synlogic…

The cybersecurity landscape rarely stands still. Organizations today face an ever-changing mix of cyberattacks, infrastructure disruptions, data breaches, and emerging AI-driven threats. At the same time, recent outages affecting major gaming platforms have highlighted how dependent consumers and businesses have become on interconnected digital services. A recent AWS-related disruption impacted PlayStation Network services, while Xbox…

The three-phase earn-in agreement gives Allied Energy a structured pathway to acquire 100% of the California gold project while validating the property’s historical exploration before committing larger amounts of capital. Key Investor Takeaways Why AGYP Stock Is in Focus Allied Energy (OTCQB:AGYP) announced it has executed a definitive three-phase earned interest option agreement with Puma…

The activation of the first clinical site marks the transition of Silexion’s lead RNAi therapy into active Phase 2/3 testing for locally advanced pancreatic cancer. Key Investor Takeaways Why SLXN Stock Is in Focus Silexion Therapeutics (NASDAQ:SLXN) announced the initiation of its Phase 2/3 clinical trial for SIL204 after activating the first study site at…

Strong demand for AI-enabled communications and enterprise customer wins drove record revenue and adjusted EBITDA, prompting Bandwidth to increase its full-year guidance. Key Investor Takeaways Why BAND Stock Is in Focus Bandwidth (NASDAQ:BAND) delivered record quarterly revenue of $220 million, a 22% increase from the prior year, while adjusted EBITDA rose 27% to $28 million,…

The acquisition transforms Processa’s pipeline with the addition of clinical-stage BTK inhibitor VT-7208, while a concurrent $200 million private placement is expected to fund development into 2029. Key Investor Takeaways Why PRCT Stock Is in Focus Processa Pharmaceuticals (NASDAQ:PRCT) announced the acquisition of clinical-stage biotechnology company Vidya Therapeutics in a stock-for-stock transaction, adding its lead…